CLOs on the Move

Phononic

www.phononic.com

 
Phononic is reimagining cooling and heating in ways never thought possible. Its breakthrough technology is transforming industries and creating new markets with innovative solid-state solutions that disrupt antiquated business models and incumbent technologies. Phononic is the critical element of innovation needed to radically change what it means to be efficient, effective and sustainable. The company has been named to the 2016, 2017 and 2019 CNBC Disruptor 50 lists, received the US EPA’s 2017 Emerging Tech Award, R&D 100 Award and more.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Vistec Semiconductor Systems

Vistec Semiconductor Systems is a Fremont, CA-based company in the Computers and Electronics sector.

Somark Innovations

Somark Innovations is a Saint Louis, MO-based company in the Computers and Electronics sector.

Medina Associates

Medina Associates is a Rose Valley, PA-based company in the Computers & Electronics sector.

Morse Micro

Morse Micro is a fabless semiconductor company that develops low power, long range Wi-Fi HaLow chips for the Internet of Things (IoT) market.

Xceleron

Xceleron believes that AMS technology and our expertise can get life-changing products (drugs and biobased) quickly and cost-effectively to people who need them.  We work with integrity and an open mind and are driven by science and the spirit of collaboration. Founded in 1997 in York, UK, and now headquartered in Germantown, Maryland, Xceleron pioneered human microdose and microtracer techniques using AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I, and Phase II/III clinical trials. Xceleron’s experience is especially valuable because the characteristics of many contemporary small molecules (low solubility, long half-life and disproportionate human metabolites) mean that their early pharmacokinetic and metabolic characterization is critical to the cost-effectiveness of clinical development.